World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 9 January 2017
Main ID:  NCT03002675
Date of registration: 15/12/2016
Prospective Registration: No
Primary sponsor: Ingrid Jazet
Public title: Exenatide and Brown Adipose Tissue exe01
Scientific title: The Effect of Exenatide on Brown Adipose Tissue Activity and Energy Expenditure in Healthy Young Men
Date of first enrolment: August 2016
Target sample size: 24
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03002675
Study type:  Interventional
Study design:  Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Netherlands
Contacts
Name:     Ingrid Jazet, MD, PhD
Address: 
Telephone: +33-715268161
Email: i.m.jazet@lumc.nl
Affiliation: 
Name:     Ingrid Jazet Jazet, MD
Address: 
Telephone:
Email: i.m.jazet@lumc.nl
Affiliation: 
Name:     Ingrid Jazet, MD
Address: 
Telephone:
Email:
Affiliation:  Leiden University Medical Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- Dutch South Asian or white Caucasian male, 20-30 years

- BMI = 18 and = 25 kg/m2

- Good general health

Exclusion Criteria:

- BMI > 25 kg/m2 or < 18 kg/m2

- Use of medication known to influence glucose and/or lipid metabolism or brown fat
activity (e.g. beta blockers)

- Any significant chronic disease

- Renal, hepatic or endocrine disease

- Smoking

- Participation in an intensive weight-loss program or vigorous exercise program during
the last year before the start of the study

- Recent participation in other research projects (within the last 3 months),
participation in 2 or more projects in one year

- Contraindications for undergoing an MRI scan:

- Presence of non-MR safe metal implants or objects in the body.

- Pacemaker, neurostimulator, hydrocephalus pump, drug pump, non-removable hearing aid,
large recent tattoos.

- Claustrophobia

- Tinnitus or hyperacusis



Age minimum: 20 Years
Age maximum: 30 Years
Gender: Male
Health Condition(s) or Problem(s) studied
Obesity
Intervention(s)
Drug: Bydureon
Primary Outcome(s)
The effect of exenatide on BAT activity and energy expenditure in healthy young South Asian compared to white Caucasian men [Time Frame: End of the study, up to 21 months]
Secondary Outcome(s)
Visualisation of BAT as measured with MRI scan compared to FDG-PET CT [Time Frame: End of the study, up to 21 months]
Secondary ID(s)
P16.078
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
AstraZeneca
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history